BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

662 related articles for article (PubMed ID: 21355440)

  • 1. Synthesis of novel 6-substituted-3(2H)-pyridazinone-2-acetyl-2-(substituted/-nonsubstituted benzal)hydrazone derivatives and acetylcholinesterase and butyrylcholinesterase inhibitory activities in vitro.
    Utku S; Gökçe M; Orhan I; Sahin MF
    Arzneimittelforschung; 2011; 61(1):1-7. PubMed ID: 21355440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and antimicrobial, acetylcholinesterase and butyrylcholinesterase inhibitory activities of novel ester and hydrazide derivatives of 3(2H)-pyridazinone.
    Ozçelik AB; Gökçe M; Orhan I; Kaynak F; Sahin MF
    Arzneimittelforschung; 2010; 60(7):452-8. PubMed ID: 20712136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Series of New Hydrazone Derivatives: Synthesis, Molecular Docking and Anticholinesterase Activity Studies.
    Bozbey İ; Özdemir Z; Uslu H; Özçelik AB; Şenol FS; Orhan İE; Uysal M
    Mini Rev Med Chem; 2020; 20(11):1042-1060. PubMed ID: 31660824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, Synthesis and Investigation of New Diphenyl Substituted Pyridazinone Derivatives as Both Cholinesterase and Aβ-Aggregation Inhibitors.
    Kilic B; Erdogan M; Gulcan HO; Aksakal F; Oruklu N; Bagriacik EU; Dogruer DS
    Med Chem; 2019; 15(1):59-76. PubMed ID: 29792155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and analgesic and anti-inflammatory activities 6-substituted-3(2H)-pyridazinone-2-acetyl-2-(p-substituted/nonsubstituted benzal)hydrazone derivatives.
    Gökçe M; Utku S; Küpeli E
    Eur J Med Chem; 2009 Sep; 44(9):3760-4. PubMed ID: 19535179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new series of pyridazinone derivatives as cholinesterases inhibitors: Synthesis, in vitro activity and molecular modeling studies.
    Özçelik AB; Özdemir Z; Sari S; Utku S; Uysal M
    Pharmacol Rep; 2019 Dec; 71(6):1253-1263. PubMed ID: 31675671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Iodinated Hydrazide-hydrazones and their Analogues as Acetyl- and Butyrylcholinesterase Inhibitors.
    Krátký M; Štěpánková Š; Brablíková M; Svrčková K; Švarcová M; Vinšová J
    Curr Top Med Chem; 2020; 20(23):2106-2117. PubMed ID: 32814531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of novel 2,6-disubstituted pyridazinone derivatives as acetylcholinesterase inhibitors.
    Xing W; Fu Y; Shi Z; Lu D; Zhang H; Hu Y
    Eur J Med Chem; 2013 May; 63():95-103. PubMed ID: 23466605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective inhibition of butyrylcholinesterase by singlet oxygen-generated melatonin derivatives.
    Moleda Z; Wojtasiewicz K; Panasiewicz M; Czarnocki Z
    J Pineal Res; 2010 Aug; 49(1):55-9. PubMed ID: 20459459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and evaluation of 4-substituted coumarins as novel acetylcholinesterase inhibitors.
    Razavi SF; Khoobi M; Nadri H; Sakhteman A; Moradi A; Emami S; Foroumadi A; Shafiee A
    Eur J Med Chem; 2013 Jun; 64():252-9. PubMed ID: 23644208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and synthesis of some new carboxamide and propanamide derivatives bearing phenylpyridazine as a core ring and the investigation of their inhibitory potential on in-vitro acetylcholinesterase and butyrylcholinesterase.
    Kilic B; Gulcan HO; Aksakal F; Ercetin T; Oruklu N; Umit Bagriacik E; Dogruer DS
    Bioorg Chem; 2018 Sep; 79():235-249. PubMed ID: 29775949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, characterization and biological screening of sulfonamides derived form 2-phenylethylamine.
    Rehman AU; Afroz S; Abbasi MA; Tanveer W; Khan KM; Ashraf M; Ahmad I; Afzal I; Ambreen N
    Pak J Pharm Sci; 2012 Oct; 25(4):809-14. PubMed ID: 23009998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and acetylcholinesterase and butyrylcholinesterase inhibitory activities of 7-alkoxyl substituted indolizinoquinoline-5,12-dione derivatives.
    Wu ZP; Wu XW; Shen T; Li YP; Cheng X; Gu LQ; Huang ZS; An LK
    Arch Pharm (Weinheim); 2012 Mar; 345(3):175-84. PubMed ID: 21989769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, characterization and biological screening of 5-substituted-1,3,4-oxadiazole-2yl-N-(2-methoxy-5-chlorophenyl)-2-sulfanyl acetamide.
    Rehman A; Fatima A; Abbas N; Abbasi MA; Khan KM; Ashraf M; Ahmad I; Ejaz SA
    Pak J Pharm Sci; 2013 Mar; 26(2):345-52. PubMed ID: 23455206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, characterization, oxidative degradation, antibacterial activity and acetylcholinesterase/butyrylcholinesterase inhibitory effects of some new phosphorus(V) hydrazides.
    Gholivand K; Hosseini Z; Farshadian S; Naderi-Manesh H
    Eur J Med Chem; 2010 Nov; 45(11):5130-9. PubMed ID: 20801550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and in vitro evaluation of novel rhodanine derivatives as potential cholinesterase inhibitors.
    Krátký M; Štěpánková Š; Vorčáková K; Vinšová J
    Bioorg Chem; 2016 Oct; 68():23-9. PubMed ID: 27428597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, biological evaluation of 9-N-substituted berberine derivatives as multi-functional agents of antioxidant, inhibitors of acetylcholinesterase, butyrylcholinesterase and amyloid-β aggregation.
    Shan WJ; Huang L; Zhou Q; Meng FC; Li XS
    Eur J Med Chem; 2011 Dec; 46(12):5885-93. PubMed ID: 22019228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel pyridazinone derivatives as butyrylcholinesterase inhibitors.
    Dundar Y; Kuyrukcu O; Eren G; Senol Deniz FS; Onkol T; Orhan IE
    Bioorg Chem; 2019 Nov; 92():103304. PubMed ID: 31561108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aminopyridazines as acetylcholinesterase inhibitors.
    Contreras JM; Rival YM; Chayer S; Bourguignon JJ; Wermuth CG
    J Med Chem; 1999 Feb; 42(4):730-41. PubMed ID: 10052979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, in vitro assay, and molecular modeling of new piperidine derivatives having dual inhibitory potency against acetylcholinesterase and Abeta1-42 aggregation for Alzheimer's disease therapeutics.
    Kwon YE; Park JY; No KT; Shin JH; Lee SK; Eun JS; Yang JH; Shin TY; Kim DK; Chae BS; Leem JY; Kim KH
    Bioorg Med Chem; 2007 Oct; 15(20):6596-607. PubMed ID: 17681794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.